DNA-Technology at MICROCON 2025: A Step Towards Strengthening Our Position in the Indian

From October 30 to November 2, 2025, our company took part in the international conference MICROCON 2025, dedicated to clinical microbiology and infectious diseases. The event, which brought together leading experts from around the world, served as an important platform for presenting advanced solutions in the field of molecular diagnostics.

The scientific program focused on key issues in modern microbiology. Among the most significant presentations were a lecture by Dr. Mandira Varma-Basil on "Nontuberculous Mycobacteria: The Mysterious Quicksand Territory," an overview of new diagnostic methods by Dr. Kusum Sharma, and a talk by Dr. Richa Mishra on the epidemiology and patient profile of NTM infections.

At its booth, DNA-Technology showcased its latest developments. The centerpiece of the exhibition was the new generation Real-Time PCR instrument — the DTprime II, which garnered significant interest from specialists. Visitors also had the opportunity to explore the company's full product portfolio.

The booth was primarily visited by practicing microbiologists from public and private laboratories. This audience showed the greatest interest in new reagent kits for PCR diagnostics, such as FEMOFLOR®II, HBV, and HPV SCREEN HR14.

In addition to healthcare professionals, representatives from distribution companies expressed strong interest in collaboration. "Participation in MICROCON 2025 fully aligns with our company's strategy to promote our products and strengthen our position in the Indian market. The event provided an excellent opportunity for us not only to present our innovations but also to lay the groundwork for new, mutually beneficial partnerships," a representative of DNA-Technology commented.